Replies to post #64322 on Anavex Life Sciences Corp (AVXL)

[joshalex5]

The fda approves some drug with huge side affects see commercials on tv. 2-73 is incredible just for that.

[XenaLives]

I'm in partial agreement with your statement, but don't necessarily think that it has to be "after" the 2-3 trial. There's also the possibility of early results from the 2-3 trial allowing generous compassionate use terms or early approval on outstanding data.

2-73 is not close to this George. The FDA will want to see more data than what the phase 2a can provide, especially because it's unblinded with no placebo arm. Possibly after the phase 2B/3 pivotal trial, but no sooner unless data is irrefutably amazing.